"What lies beneath it all?" - an interview study of GPs' attitudes to the use of guidelines by Carlsen, Benedicte & Norheim, Ole Frithjof
BioMed CentralBMC Health Services Research
ssOpen AcceResearch article
"What lies beneath it all?" – an interview study of GPs' attitudes to 
the use of guidelines
Benedicte Carlsen*1 and Ole F Norheim2
Address: 1Stein Rokkan Centre for Social Studies, The University of Bergen, Nygårdsgaten 5, 5015 Bergen, Norway and 2Department of Public 
Health and Primary Health Care, The University of Bergen, Kalfarveien 31, 5018 Bergen, Norway
Email: Benedicte Carlsen* - benedicte.carlsen@rokkan.uib.no; Ole F Norheim - Ole.Norheim@isf.uib.no
* Corresponding author    
Abstract
Background: General practitioners (GPs) adopt clinical practice guidelines to varying degrees.
Several factors have been found to influence application of guidelines in practice and the GP is
apparently the key actor. Studies are needed to increase our understanding of how GPs' attitudes
influence their use of guidelines. In this study we explored GPs' attitudes to guidelines.
Methods: In 2007 we conducted six semi-structured group interviews with a purposive sample of
27 Norwegian GPs. The participants were encouraged to discuss guidelines they were familiar with,
the evidence base of guidelines, professional autonomy and doctor-patient relations. We used
thematic content analysis to extract central themes and arguments.
Results: When deciding whether tfollow guideline recommendations, GPs consider whether
guidelines are trustworthy, whether they suit patients and whether the recommended action is
feasible. There were two important findings. First, the GP's were concerned that guidelines may be
more heavily influenced by economic considerations than clinical ones. Second, in contrast to
earlier findings, changes in recommendations and disagreement between experts were mostly
viewed positively.
Conclusion: This study underscores the need for transparency in the process of development and
implementation of guidelines. To enhance the use of guidelines, primary care physicians should be
involved in the process of developing guidelines and the process should be transparent and explicit
regarding the evidence base and economic considerations.
Background
Clinical guidelines can be thought of as "generic decisions
– recommendations intended for a collection of patients
rather than for a single patient" [1]. Clinical practice
guidelines have also been defined as "user-friendly state-
ments" for a collection of patients, based on the best exter-
nal evidence [2]. Although the demarcation is not always
clear, it is useful to distinguish between proscriptive (reg-
ulatory) guidelines which are associated with rationing
health care, and prescriptive guidelines which aim to
encourage best clinical practice even if this recommends
increased use of interventions [3]. Descriptive studies
indicate that clinical practice guidelines are read and
adopted to varying degrees [4,5]. In particular it seems to
be difficult to secure adherence to guidelines among gen-
eral practitioners (GPs), who are in many ways an auton-
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concluded that only a few of the current guidelines are
known to and used by GPs [8].
Surveys on the implementation of guidelines have catego-
rised some of the major barriers to guideline adherence
which can be related to practitioner, patient, organisa-
tional or guideline factors [9-11], although the practi-
tioner appears to be the key actor. There has been a call for
explorative studies to increase our understanding of how
GPs' attitudes are related to the use of guidelines in med-
ical decision making [12,13], but hitherto only a few stud-
ies have explored what lies behind GPs' views of
guidelines [3].
A recent review and synthesis of interview studies of GPs'
attitudes to guidelines identified common barriers to
implementation [3]. This study found that barriers are
similar across studies and countries and the barriers
described in the qualitative explorative studies do not dif-
fer much from barriers identified in quantitative surveys,
although the qualitative studies offer a more in-depth
understanding of what lies behind GP's attitudes and how
they are related. The review study identified six main cat-
egories of barriers to the implementation of guidelines:
questioning the content of the guideline, applying evi-
dence in practice, preserving a good doctor-patient rela-
tionship, professional responsibility, practical issues, and
the format of guidelines. The study also showed the use-
fulness of distinguishing between proscriptive and pre-
scriptive guidelines.
Most qualitative studies have explored clinicians' attitudes
to the implementation of just one or a few specific guide-
lines, while some recent studies include several guidelines
for comparison [6,14,15]. These studies investigate the cli-
nician's point of view, but the results are also inevitably
coloured by the guidelines in question, as well as the proc-
ess of implementation and the policy context of imple-
mentation. In a more general study, where the
participants choose which guidelines to discuss, it is pos-
sible to see which guidelines the GPs are currently aware
of and which are debated. Carlsen et al's review found
only one study of GPs' attitudes to guidelines in general
[12], and two that studied different guidelines from a
common source (National Institute for Health and Clini-
cal Excellence – NICE) [15,16]. An important barrier iden-
tified in these studies is the belief among GPs that
guidelines based on research conducted in other settings
is not valid in their own general practice. Generally GPs
held the opinion that clinical experience and judgement
should overrule guidelines. Practical constraints such as
lack of time to acquaint oneself with guidelines and the
evidence behind them were also central.
The aim of our study was to explore GPs' attitudes to clin-
ical practice guidelines in general. In this paper, we focus
on the factors Norwegian GPs emphasize when they con-
sider whether or not to follow guidelines.
The Norwegian Setting
In a European perspective, Norwegian GPs are presented
with relatively few guidelines, and Norwegian general
practice is generally characterised by low levels of moni-
toring and control. In Norway there is yet no superior
source of national guidelines for general practice such as
NICE is for British GPs. Several government led institu-
tions, as well as some independent and private organisa-
tions, and pharmaceutical companies, have all produced
clinical guidelines for general practice in Norway in recent
years. Comparatively few guidelines are issued by the gov-
ernment led institutions.
Methods
One of the researchers (the social scientist – BC) con-
ducted six semi-structured group interviews with a purpo-
sive sample of 27 Norwegian GPs from the counties of
Hordaland (20 GPs) and Oslo (7 GPs). A letter of invita-
tion was sent to 93 doctors' educational groups. The final
sample was selected from 11 groups that contacted the
research team following the invitation. The sample was
chosen to reflect variation in age, gender, professional
experience, list size, urbanisation, and patient popula-
tions of different socioeconomic levels. The participants
in the groups knew each other from earlier group meet-
ings, and the interviews were conducted at the usual place
and time for group meetings; usually in the lunch room of
one of the participants' practice. At the start of the inter-
views all participants were informed about anonymity
issues and their right to withdraw from the study at any
point. Subsequently they signed an informed consent
form and filled in a short questionnaire of background
information (Table 1).
New interviews were initiated until a point of data satura-
tion was reached. Interviews lasted approximately one
hour and were recorded and transcribed verbatim.
The interview guide included the following themes:
• What characterises good guidelines?
• Trust in the evidence and the guidelines
• Barriers to using guidelines
• How guidelines influence professional autonomy and
relationship with patientsPage 2 of 11
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guidelines and to illustrate their points with examples
from practice. However, no definition of clinical practice
guidelines was presented by the researchers.
Thematic content analysis [17] was applied to search the
data for common themes and arguments. Both authors
read the interviews thoroughly and then defined and dis-
cussed emergent themes and possible codes until agree-
ment was reached. The first author coded the interviews,
while the second author checked and revised the coded
texts. Informant validation was conducted by inviting all
participants to assess the preliminary manuscript of this
paper. The manuscript was distributed to all of the groups,
but only one group provided comments.
Ethical approval
The project has been approved by the Privacy Ombuds-
man against the privacy and license requirements of the
Data Inspectorate in relation to the Personal Data Act and
Health Register Act.
Results
The sample profile was similar to the population of GPs
in Norway in terms of age, gender and list size, while the
proportion with open lists (i.e., doctors with fewer
patients on their list than they would like) was somewhat
smaller in our sample (Table 1).
As it was left to the participants to describe guidelines,
they referred to a broad spectrum of rules, regulations, rec-
ommendations and information which they associated
with the concept of guidelines. A limited number of
guidelines and related health issues were repeatedly dis-
cussed in the groups. The most frequently mentioned
were guidelines for: primary prevention of cardiovascular
disease, diabetes, antenatal care, COPD/asthma, and
mammography screening.
The participants' knowledge of and reported use of guide-
lines varied, but there was general agreement about which
factors are important when considering whether to follow
recommendations. The interviews indicate three main cat-
egories of factors that influence GPs' decisions about fol-
lowing guidelines (See Table 2 for an overview).
Factors influencing guideline adherence
1. Can I trust the recommendations?
A common predicament for the GPs when assessing
guidelines was a lack of trust in the recommendations.
The most evident source of distrust among the partici-
Table 1: Sample profile compared to all Norwegian GPs
Variable Sample* GPs in Norway**
Number of GPs 27 3862
Male GPs 67% 68%
Age (mean) 45 47
Current list size (mean) 1110 1196
GPs with open list 31% 46%
* Our data from the questionnaire. The proportions given are 
calculated on the basis of the total number of answers to each 
question.
** Data from the Norwegian Labour and Welfare Organisation and 
the Norwegian Medical Association: Available at http://www.nav.no/
page?id=1073743257 and http://www.legeforeningen.no/
index.gan?id=124987 Accessed August, 2007.
Table 2: Questions considered by GPs when deciding whether to follow a guideline
1. Can I trust the recommendations? a. Are the recommendations driven by economic motives (rationing or profit)?
b. Is the source trustworthy?
c. Is the evidence trustworthy?
2. Are the recommendations consistent with this patient's needs? a. Is it possible to say no to patients' requests without disappointing them?
b. Are patients likely to comply with recommended treatment?
3. Is following the recommendations feasible? a. Are the recommendations easily accessible and comprehensible to me and 
the patient?
b. Have I got the time to assess and follow the recommendations?
c. Have I got the necessary skills and resources to follow the 
recommendations?Page 3 of 11
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shadow clinical considerations. The participants feared
that government guidelines designed for cost control and
rationing are clinically unsound and do not recommend
best practice or adequate health care. It was suspected that
hidden economic motives often lie behind guidelines.
However an explicit rationing motive was regarded as
acceptable.
I think this is moving the focus away from the patient and
towards a set of rules which is not about patients but about
money.
(Male GP, Oslo)
GP: I am concerned that money is all too important. I am afraid
the economic issues will overshadow other important values.
Researcher: That economic issues are included in the decision
without your being aware of it?
GP: Yes, that that is what lies beneath it all.
(Female GP, Oslo)
I think it's reasonable from the authorities' side to have guide-
lines which say we have economic boundaries, which mean we
can't do everything we could, but then it should be stated that
that is what is happening. And there aren't many people who
dare to say that. So I am worried that guidelines come out with
an underlying agenda which we don't get to see.
(Male GP, Oslo)
Some of the participants found it difficult to "sell" cost-
cutting guidelines to patients, while others said that, in
the end, patients would understand and follow doctors'
advice if they were explicitly informed about cost issues.
Both these points of view suggest that the doctor's own
attitude to guidelines often is transmitted to the doctor-
patient relationship. The doctor's own suspicion of a hid-
den agenda of cost control was seen as a problem when
the doctor had to negotiate new routines with patients,
whereas if the doctor had accepted and understood the
guidelines, this also seemed to be reflected in patients'
attitudes.
But it is worse with medicines for blood pressure, and then
sometimes I think it's a hassle to have to start everyone on thi-
azides. And then I'm maybe a bit biased so that patients notice.
So they get the side effects they expect so we can put them on
the other drugs.
(Female GP, Oslo)
I see that people think it seems quite reasonable. If the drugs are
just as good, and I say we have been told to use it to save a cou-
ple of million kroner a year. Then they say, yes, that's fine.
(Male GP, Hordaland)
Sometimes GPs agreed with health authorities that ration-
ing is necessary and that economic considerations should,
therefore, be part of the guideline basis. Nevertheless they
had little faith in the economic evaluations behind spe-
cific guidelines. They were suspicious that the economic
evaluations had been too simplistic, i.e. not including any
extras that the implementation of the guideline would
entail, or they were doubtful that the health authorities
could be trusted to use savings in other more important
areas.
The problem with this type of guidance from the state medicines
agency is that nobody counts the extra doctor time used. How
much extra treatment costs does the welfare office get for
appointments and fees for doctors using time on this? It may not
be very much, but it will outweigh a good part of the effect, and
we can't see that health economists have looked at this.
(Male GP, Hordaland)
It's easy to see the importance of using the right medicines, but
it's clear that part of the problem with, for example, reimburse-
ment of drugs is that it appears very random and unfair. When
the state medicine's agency says no, the industry goes to the par-
liament (...) and gets them to speak up for a medicine with lit-
tle effect. It obviously seems a bit dumb that I'm supposed to sit
here in my practice and change all my patients to a cheaper
copy of the drug for the state to save money which it then doles
out at random to huge pharmaceutical companies.
(Male GP, Hordaland)
Fear of economic motives led to distrust of both govern-
mental and pharmaceutical guidelines albeit for very dif-
ferent reasons. The GPs frequently referred to the
conventional truth that recommendations and courses
sponsored by the industry are driven by a chase for profit
and cannot be trusted. Some even said that they refused to
read such recommendations.
They both have their agenda. The pharmaceutical industry is
for profit and the state wants to save money. So in a way it's two
sides of a money issue.
(Male GP, Hordaland)
If the pharmaceutical company has financed it, it goes in the
bin unread. Even if it might be very good. And much the same
applies to certain guidelines from the state. Because the statePage 4 of 11
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can't always trust what comes from there.
(Male GP, Hordaland)
In contrast to the scepticism towards proscriptive (regula-
tory) guidelines from health authorities or the prescriptive
(innovative) guidelines from the pharmaceutical indus-
try, guidelines developed by general practitioners were
unanimously trusted. The guidelines GPs claimed most
adherence to were treatment programmes which were
developed by general practitioners or by a multi-discipli-
nary group that included general practitioners. This was
seen both as a guarantee that the guidelines were not eco-
nomically motivated and also that the authors were famil-
iar with the complex reality of general practice.
I feel that the further they are from us, from knowing what
daily life is like for us, the less faith I have in them. I have most
faith in what is presented by those who know what our every day
is like.
(Female GP, Oslo)
Clearly something which is done as a voluntary effort, for free,
by Norwegian GPs, I have great faith in.
(Male GP, Hordaland)
For the GPs to believe in the recommendations, it seemed
necessary that they trusted the evidence behind the guide-
lines. The participants were sceptical about transferring
evidence produced in population based studies or hospi-
tal based experiments to general practice and individual
patients. Many were of the opinion that guidelines devel-
oped by hospital specialists had little relevance to general
practice and that possible side-effects were often not suffi-
ciently examined. Others had more faith in the specialists'
recommendations and were happy to leave some of the
responsibility for clinical decisions to those who they
assumed had better knowledge of the evidence.
Yes, we don't really know much about how it is for that partic-
ular person. This is aggregated data, and we don't know any-
thing about what the individual's risk level actually is. We can
try to work it out, but it is based on statistics.
(Male GP, Hordaland)
It's not certain that the gain is as great as we think. They
haven't done studies on this population. Guaranteed not. Stud-
ies can be done for populations with higher risks than the nor-
mal population. There has to be someone sick to be able to
measure the difference.
(Male GP, Hordaland)
I think you maybe feel a bit of a need to believe (in guidelines).
I have to believe some of what comes from the sources we trust.
Because there are so many choices, I feel, in this job. And then
it's a bit like sharing some of the responsibility in a way.
(Male GP, Oslo)
A recurring theme in the interviews was how to relate to
the fact that recommendations are constantly changing
and evidence often debated, reflecting disagreement
among the experts. Generally the participants accepted
that guidelines are changing and preferred guidelines that
were constantly updated, and they saw open discussion as
an advantage which increased trust in the guidelines.
Hence it was vital that they had had the opportunity to
familiarise themselves with the evidence. On the other
hand the same participants also sometimes said that they
found expert disagreement confusing, especially if they
had not had the time to assess the evidence themselves.
Some pointed out that disagreement and debate is posi-
tive also because it suggests that it is legitimate to be criti-
cal to the recommendations. Others had the opposite
reaction; in cases where there is a lot of disagreement
about what is best practice, it is safer and easier to stick to
the guidelines.
Well, it's not just one person sitting giving their opinion. It's a
discussion and a process the whole time. That gives me more
faith in it.
(Male GP, Oslo)
GP1: Discussion is an advantage.
GP2: Yes, it confirms that we are involved in an academic dis-
cipline, not just some kind of slavery.
GP1: Yes, that we have to listen to differences and then we have
our own experiences. When we have treated 100 patients with
blood pressure drugs, we get a bit of a feeling of what gives side-
effects and what is effective reducing blood pressure.
(GP1: Female GP, Oslo; GP2: Male GP, Oslo)
I'm pretty gullible. I believe everything I hear! (laughs). I
believe in a way what is written in the Norwegian medical jour-
nal. That I believe. Right until someone writes some weighty
critique of those articles which makes me realise, 'Oh, so that
wasn't quite right at all then?' So, what I like is maybe places
where you see that it's a discussion, the way it is in the journal.
It's, in a way, open, a place where you get research and theories
presented, but there's a chance for others to come with counter-Page 5 of 11
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me, in a way, a bit secure that here you get all kinds of opinions,
and if something is completely wrong, then if I read the next
journal, I'll realise.
(Female GP, Oslo)
2. Are the recommendations consistent with this patient's needs?
A recurring theme in the interviews was whether following
the guidelines would allow the individual patient's needs
and expectations to be fulfilled. The GPs emphasised that
they had first hand knowledge of the patients' ailments,
expectations of the consultation and life circumstances.
People's anxiety about potential health problems and
their knowledge about the possibilities for screening and
treatment as well as about their rights as patients were fre-
quently discussed in the groups as potential obstacles to
adhering to guidelines. Some patients were seen as
demanding and several participants emphasised a desire
to get patients' appreciation. In the participants' experi-
ence, the aim of satisfying patients frequently conflicted
with adhering to guidelines. On the other hand a few GPs
reported that they referred to guidelines to avoid having
sole responsibility for uncomfortable rationing decisions.
If we want to survive. If we are going to find a solution for the
patient sitting opposite us, we have to compromise on a lot of
these guidelines. We have after all learnt to sniff our way for-
ward to what is possible and maybe what is best for the patient.
Even if we don't follow all the guidelines.
(Male GP, Hordaland)
And patients have their own preferences too. Regarding use of
medicines, what symptoms they can tolerate, and what level of
blood pressure, what risk they are willing to take, how they are
willing to let medication influence their life and what medi-
cines they are prepared to take.
(Male GP, Hordaland)
The situation where guidelines recommended more treat-
ment than the GPs or the patients themselves deemed
suitable was discussed less. In some cases GPs said that
they respected and understood patients' wishes to abstain
from treatment.
I had a patient. He was nearly 80 years old and a bit confused,
but I had the discussion. Shall we try Maravan? And I put for-
ward the arguments for and against, that you can reduce the
risk of brain haemorrhage, but on the other hand, if you start
messing about with your medicines, that can be risky too. We
agreed after a very pleasant discussion that we would use Albyl
instead. It is not so well documented, but it was acceptable, and
then you avoid a blood test every four weeks. So I felt that was
very meaningful, and the patient lived several more years and
died of something completely different.
(Male GP, Hordaland)
Guidelines are often very schematic, and life isn't always so
simple and so you have patients who are very sceptical about
medicines or who have been allergic to loads of stuff, and would
rather not have it even if the guidelines say they should. ...
There is something about life not being so simple that you can
slot it into a framework. You have to have a bit of understand-
ing for that, have a dialogue with the patient, and try to work
towards a solution that functions, and sometimes that isn't
quite according to the book.
(Female GP, Hordaland)
3. Is following the recommendations feasible?
The participants reported busy days in their practices.
They felt there was no time to update oneself on the med-
ical literature or on the evidence behind the guidelines or
perhaps even to read guidelines. During consultations the
GPs depended on the guidelines being quick and easy to
look up and read. Following the recommendations was
often regarded as too time consuming if it involved
explaining or convincing patients. Some also noted that it
is sometimes difficult to make patients accept a change in
guidelines, especially when patients are used to a treat-
ment that is no longer recommended.
There is a lot of good work behind the formulation of these
guidelines. But they become so detailed that I can't remember
more than a little. Can always look it up, but you don't have
time when you sit there with a patient or you are already a bit
behind schedule.
(Male GP, Hordaland)
It's clear, when you change guidelines, like with these allergy
medicines, which came into force on the first of May, in the
middle of the worst pollen season, and where specialists have a
practice where one medication has been preferred, and most of
the patients are on it. And then, first, patients ring to order a
repeat prescription, and you have to argue that they should try
some other things first, then you have to check if they have used
it, you have to test it out, whether it works as well or if there are
side effects, and then you have to write an evaluation in the
record, and then, if it for one reason or another didn't work
properly or had side effects, you can change back again. You
find yourself having to argue it out every time you write a new
prescription. There is a terrible amount of extra work in that!
(Female GP, Hordaland)
In general participants thought that GPs should be
informed about which guidelines to follow and where toPage 6 of 11
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guidelines and their revisions. They found it difficult to
find the relevant guidelines since they appear in different
sources.
The regulations for reimbursement of medicines are pretty com-
plicated. It takes a lot of time to understand them. The worst
thing is that no-one sends them to you. You just have the
responsibility of reading them on the internet and you don't
even know what you have to read.
(Male GP, Hordaland)
You don't have time after a 50 hour working week to sit in the
evenings and read on the internet.
(Female GP, Hordaland)
Among existing guidelines the GPs preferred those that
were easy accessible. The format should be short and sim-
ple enough to read in a short time, albeit comprehensive
enough to be convincing. Guidelines with access to
updated and graded recommendations, depending on the
strength of the evidence base, were both easier to trust and
easier to "sell" to patients. Electronic sources were gener-
ally rated positively for their easy access and convenience
when looking up a specific problem or guideline. One
advantage of electronic sources was that information
could be checked without the patient being aware of it,
which made it easier to be convincing. Many mentioned
the need for patient leaflets.
In addition, the process of implementation was discussed
several times. A transparent process demonstrating the
rationale behind the guidelines with a thorough introduc-
tion was preferred.
The good thing about NEL (Electronic Handbook for Norwe-
gian Doctors) is that it gets updated. You know they are written
by GPs for GPs. They write up the references. And it is built up
in a way that suits the way we work everyday. If we know what
it is, wonder if there is anything new in the treatment, we can
just click to it and get straight to the chapters. It's easy.
(Male GP, Hordaland)
(About guidelines on antenatal care) They have credibility.
Partly because they have graded the strength of the advice.
Where the documentation is weak, they are cautious. Where
the documentation is strong, they are more definite (...) They
look systematically at the validity of the research and that also
allows us to evaluate each recommendation, how much weight
we should put on it, how much we should be inclined to follow
it. So that for me is an example of a pretty good guideline. A
process which allowed for discussion.
(Male GP, Hordaland)
I think most of us have pretty limited time to go systematically
through new evidence (...) An easy to use format will have
more effect than one which is not so easy to use. Regardless of
whether is has a sound basis or is reasonable.
(Male GP, Hordaland)
Discussion
The participants were asked to mention and discuss guide-
lines they knew about and related to in their practices, and
this resulted in enthusiastic discussions about a relatively
low number of guidelines. The finding that the GPs seem
to relate to only a few guidelines does not come as a sur-
prise. Treweek et al's study of reported guideline adher-
ence also found a lack of knowledge about Norwegian
guidelines [8], and the best known guidelines are similar
in the two studies.
As in earlier studies, the GPs in this study complain about
lack of time to update themselves on evidence and the
requirements of new guidelines. This discussion was
closely linked to scepticism about the evidence. Some of
the participants indicated that when they had the time
and opportunity to update themselves on the evidence
and guidelines and to inform patients, they were far more
positive about the guideline recommendations, and
found it easier to convince patients. Participants often dis-
trusted governmental guidelines and also repeatedly
expressed concern about the influence of the pharmaceu-
tical industry, which they related to the introduction of
new drugs or treatment goals (prescriptive guidelines):
Several GPs voiced a fear that economic gain motivates
undue recommendations and this may lead to medicalisa-
tion. The participants agreed that general practitioners
should be involved in developing guidelines for general
practice. This is in line with earlier studies associating
guideline adherence with participation in guideline con-
struction [18].
The reasons for scepticism towards guidelines emerging in
this study are comparable to barriers identified in earlier
European and US studies including Langley et al's general
guideline study and the recent surveys of guideline adher-
ence among Norwegian GPs [3,8,12,19]. This overall pic-
ture was expected inasmuch as Carlsen et al's [2007]
qualitative review noted similar types of barriers across
countries. However, two conspicuous aspects of our
results have not been highlighted in earlier studies and
merit further discussion; the participants concern with
cost issues and their predominantly positive view of
changing evidence.Page 7 of 11
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guidelines in general, the underlying concern that eco-
nomic motives may be overruling clinical motives
emerged as a key finding, and the most obvious reason for
distrusting guidelines in this study was GPs' fear that eco-
nomic considerations were weighted more than clinical
considerations. This attitude emerged very clearly through
the group discussions even though the participants were
not specifically asked about economic considerations.
Similar findings have been mentioned in a few earlier
studies, but it has not been found to be a central concern
[16,20]. A fear of clinical practice guidelines being used as
covert tools of rationing may arise, if the purpose and true
rationale of the guidelines is not discussed openly [21]. In
the Norwegian setting the scepticism seems relevant as
several of the guidelines discussed in the interviews are
regulatory or include elements of rationing, while there
are no sanctions or rewards related to guideline adher-
ence. In contrast, GPs in comparable countries like The
Netherlands, Denmark and the UK have been subjected to
more extensive demands to practice cost effectiveness; in
the UK the new 2004 GP contract employs economic
incentives to increase performance and guideline adher-
ence. Recent UK evaluations suggest that the economic
incentives are effective with respect to enhancing guide-
line adherence [22]. Also the debate about using regula-
tory guidelines seems to have ceased in these countries
which could indicate that the GPs' have accepted the need
to ration health care.
Regarding proscriptive guidelines, the participants in this
study were much concerned about how economic consid-
erations influence the development of guidelines, how
economic concerns relate to clinical concerns, whether
the authorities can be trusted to divert resources saved to
where they can be used more effectively, and how ration-
ing in face to face consultations is a difficult task. In addi-
tion the GPs were sceptical about the quality of the cost-
effectiveness analyses the guidelines are based on,
whether for example the costs of changing established
routines are included in the analyses. These concerns are
probably well founded, for example, a comprehensive
review of guideline implementation by Grimshaw and
colleagues [2004] pointed out that costs of the implemen-
tation process are rarely included in guideline efficiency
studies. Also, empirical evidence that guidelines have con-
tributed to reduced costs is at best limited [23].
The claim that the health services should be cost effective
is a well-known issue of conflict between health authori-
ties and health care decision makers [24-26] and the
dilemma of balancing cost and care tied to the general
practitioners' gatekeeper role have been described in ear-
lier studies [27-29]. US studies of physicians' professional
culture indicate that a central ideal is that costs should not
be a factor in medical decision making [30]. Likewise
Carlsen et al [2007] find that when guidelines appear to
be economically motivated (proscriptive guidelines), pro-
tection of professional autonomy is given as a reason for
not following guidelines. In Norway, the debate about the
role of cost containment in health care decisions is con-
stantly newsworthy. The practice of measuring the cost-
effectiveness of medical interventions is relatively new,
e.g. the decision that new drugs should be subject to a
cost-effectiveness analysis before being recommended for
reimbursement was only introduced in 2002 [31].
In our interviews the concerns about economic agendas
were closely linked to the GPs degree of trust in the
authors of the guidelines. Scepticism towards guideline
authors has been noted as a barrier in earlier studies. Part
of the reason why concerns about economic motives
appear in our findings, may be that the general nature of
the discussions in this study allowed the participants to
explore their own reasoning and motivations. Our study
suggests that the underlying reason for distrust in authors
and guidelines is the fear that clinical concerns will be
jeopardised by economic considerations.
Another theme frequently discussed in the interviews was
how changing recommendations and disagreement about
evidence influence attitudes. This is the second interesting
finding in this study, because it only partly supports Rash-
idian et al [2007] and other studies [12,14,16,20,32] who
found that changes in recommendations evoke negative
attitudes. Rashidian et al warn that this change might be a
barrier to evidence based practice. Our findings, on the
other hand, indicate that although the participants some-
times found changing recommendations confusing, they
still welcomed debate about and updates of guidelines.
Some of the explanation for this could lie in the Norwe-
gian context which has a relatively small number of guide-
lines to keep track of. It is also possible that evidence
based medicine and transparent academic debate has
become more accepted since the other studies were con-
ducted. Sometimes the participants made apparently con-
tradictory statements, stating firmly that they preferred
debate and trusted guidelines in spite of changing recom-
mendations, and later in the interview the same partici-
pants would describe how changing evidence confused
them because they felt unable to update themselves on
research. The contradictory statements could suggest that
one of the statements represents the politically correct
view while the other statement, (arguably the one emerg-
ing as the participants become caught up in the discus-
sion), reveals the true feelings about changing guidelines.
However, the statements may also reflect true mixed feel-
ings about the inherent uncertainty of medical science,
nevertheless combined with a sincere wish to have the
opportunity to assess the confusing evidence oneself.Page 8 of 11
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fessional debate and disagreement as an affirmation of
their right to use their own independent professional dis-
cretion. Paradoxically, if this is the case the GPs may well
have positive attitudes towards changing evidence, but the
outcome may still be that they choose not to follow guide-
line recommendations.
Strengths and limitations
In contrast to the majority of earlier qualitative studies of
GPs' views of guidelines, we chose to make the interviews
open and allow them to be dominated by the participants,
and we did not restrict the discussion to one or more spe-
cific guidelines. This enabled us to identify a deeply felt
concern about economic motives behind guidelines that
has not been reported in detail before. It has been pointed
out that a danger with this approach is that it may lead the
participants to produce general statements from which it
is difficult to draw policy implications [19]. However, we
invited the participants to illustrate their points with
examples from their practices, and they did so frequently,
so their private beliefs were based on experience. Never-
theless, considering readability, only a few elaborate
examples could be fitted in to the paper, and most cited
statements represent concluding remarks made by partic-
ipants summing up detailed stories from their practices.
Apart from the fact that only one or two earlier studies
have explored GPs' attitudes to guidelines in general, an
important reason for choosing a general approach was
that we wanted to explore underlying and common prob-
lems in GPs' use of clinical recommendations so that this
could be of use to health authorities when they are plan-
ning strategies of guideline implementation. We were not
interested in how a particular guideline was received or
could be improved.
While small scale interview studies are unsuitable for sur-
veying the distribution of different attitudes within a
group, they are expected to yield data about commonly
accepted norms and attitudes [33]. In this study we were
aiming at discovering these mainstream attitudes among
Norwegian GPs. Thus, if discussion in the groups is dom-
inated by statements that are politically correct among
GPs, this is not necessarily problematic. It is to be antici-
pated that dominant group members influence the state-
ments and opinions of others, as they do in "real" group
meetings and other social settings. In this particular case,
it seemed to the researcher that the participants felt
relaxed within the groups; for example the discussions
were easy to spur and practically all participants contrib-
uted eagerly and frequently confronted each others opin-
ions. This outspokenness may be ascribed to the
participants' familiarity with each other.
Even though our main focus was to reveal general atti-
tudes among the participants, we found that it was some-
times necessary to demonstrate variance in views within
the participant group. We have used expressions like
"some" or "a few" in contrast to "frequently" and "gener-
ally" to denote the difference between consensus and
nonconforming voices. This represents a common solu-
tion to what we see as a yet unsolved challenge when
reporting qualitative findings. Exact counting of state-
ments is normally not useful in semi-structured group
interviews because not all participants will answer all
questions or make comparable statements about all sub-
themes, but expressions like "most" or "generally" are
used to underline a general and strong tendency in the
data. We do not, however, see this as an ideal solution and
are welcoming debate as to how qualitative data may be
presented in a better way.
We have reflected on the researcher's role in these inter-
views. One initial concern was that the researcher could be
perceived as an agent for the government since the project
was funded by the Research Council of Norway which is a
governmental institution. The interviewer therefore
emphasised her independence as a researcher. The fact
that the groups existed as educational groups prior to the
research project appeared to inspire confidence and free
discussion within the groups with relatively little atten-
tion to the researcher's role and background.
The standard caution for in-depth studies is to be aware
that the findings are not necessarily valid in other settings.
This also applies to this study. Nevertheless, to provide the
reader with some idea of the generalisability, we have
included a profile of the sample and all Norwegian GPs.
We have also provided some of the special context-specific
characteristics of Norwegian general practice and the kind
of guidelines used. The fact that the overall picture of con-
cerns of the participating GPs is similar to that found in
earlier European and US studies as well as in Treweek et
al's [2005] Norwegian study, increases the probability
that the findings are applicable beyond the context of this
study. However, more general studies of attitudes towards
guidelines are needed to substantiate our findings. As
noted above, the particular concern with economic con-
siderations or the relative lack of concern with changing
evidence may be typical for the Norwegian context, but
there is no reason to believe that the message this conveys
that GPs' scepticism is associated with lack of transpar-
ency and involvement in guideline development is spe-
cific of the Norwegian context.
A limitation of interview data is that they yield no certain
information about the connection between attitudes and
actions. Research indicates that positive attitudes to guide-
lines do not necessarily mean that doctors follow their rec-Page 9 of 11
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difficult to separate underlying reasons from what we
might call 'excuses'. This can be illustrated by the relation-
ship between the three main barriers depicted in this
study; distrust in guidelines, patients' desires and practical
problems: When it comes to proscriptive guidelines, doc-
tors have been accused of blaming patients and practical
problems for what is actually a lack of motivation for
rationing according to the guidelines [35]. On the other
hand, there is no doubt a constant lack of time to follow
up complicated and impractical guidelines may be a real
obstacle to motivation and trust in them. For example,
there is evidence that the format of guidelines strongly
influences attitudes towards them [36]. Furthermore,
patient preferences are supposed to be included in medi-
cal decision making, and patient preferences are, as these
findings show, influenced by whether or not there is time
to give patients reasonable information and whether the
GP trusts the evidence. As the three factors have been
described several times earlier in comparable studies, it is
plausible that they all influence adherence to guidelines
and that they all affect each other.
It is also thought provoking that British GPs seem to have
put aside the above concerns in favour of economic
rewards [22]. If attitudes conveyed in interview studies are
so easily influenced by economic incentives, are they then
mere excuses for taking the easy way out in practice? Again
it may be argued that the fact that private economic con-
cerns are of importance to GPs does not necessarily mean
that other concerns are unimportant, especially not in a
setting, such as the Norwegian, where the government
hitherto has chosen not to employ economic incentives to
implement guidelines. Rather, the possible fragility of
professional and individual concerns that the UK study
gives indications of, and these Norwegian GPs seem to
worry about, may be used as an argument against intro-
ducing economic incentives.
Conclusion
The findings suggest that Norwegian GPs should be
involved in the development of guidelines, as they already
are in some other countries. The evidence also supports
the idea that the process of developing guidelines should
be transparent; guidelines should be explicit about the
underlying purpose, especially when economic consider-
ations are part of the motivation. Comprehensive infor-
mation about the clinical and economic evaluations of
guideline recommendations should be available and this
should include calculations of the cost of changing estab-
lished routines. The recommendations themselves need
to be short, simple and include patient leaflets.
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